港股策略：2026年3月港股通成分股调整预测

Core Insights - The report predicts an upcoming adjustment to the Hong Kong Stock Connect list in March 2026, with the announcement expected on February 20, 2026, and implementation on March 6, 2026 [1][6]. Group 1: Event Description - The adjustment period for the Hang Seng Composite Index ended on December 31, 2025, and the new list of stocks for the Hong Kong Stock Connect will be released shortly [6][7]. Group 2: Potential Stocks for Inclusion - A total of 47 stocks are expected to meet the criteria for inclusion in the Hong Kong Stock Connect. The pharmaceutical and biotechnology sector has a significant representation among these potential stocks, including names such as: - Pharmaceutical and Biotechnology: 英矽智能, 中慧生物-B, 宝济药业-B, 派格生物医药-B, 劲方医药-B, 轩竹生物-B, 康臣药业, 科济药业-B, 海西新药, 长风药业, 维立志博-B, 林清轩, 歌礼制药-B [7]. - Software Services: 经纬天地, 希迪智驾, 卓越睿新, 诺比侃, 赤子城科技, 量化派, 迅策, 聚水潭, 果下科技, 五一视界, HASHKEY HLDGS, 卧安机器人, 滴普科技 [7]. - Non-Bank Financials: OSL Group, 耀才证券金融, 轻松健康, 国富量子 [7]. - Other sectors include metals, hardware, banking, automotive, consumer retail, household goods, appliances, machinery, defense, industrial trade, utilities, and medical devices [7]. Group 3: Performance Expectations - Stocks that are about to be included in the Hong Kong Stock Connect are expected to perform strongly. Historical backtesting shows that stocks included in the Connect tend to exhibit significant excess returns before and after their inclusion, particularly with the anticipated continued inflow of southbound capital [8].